{"doi":"10.1038/nature09399","title":"Purified human BRCA2 stimulates RAD51-mediated recombination","abstract":null,"journal":"Nature","year":2010,"id":42166,"datarank":11.772978993475235,"base_score":6.556778356158042,"endowment":6.556778356158042,"self_citation_contribution":0.9835167534237065,"citation_network_contribution":10.789462240051527,"self_endowment_contribution":0.9835167534237065,"citer_contribution":10.789462240051527,"corpus_percentile":null,"corpus_rank":null,"citation_count":703,"citer_count":200,"citers_with_citation_signal":200,"citers_with_endowment":200,"datacite_reuse_total":25,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":202210,"name":"Aura Carreira","orcid":null,"position":1,"is_corresponding":false},{"id":202211,"name":"Stephen C. Kowalczykowski","orcid":null,"position":2,"is_corresponding":false},{"id":202209,"name":"Ryan B. Jensen","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":6.556778356158042,"endowment":6.556778356158042,"datacite_reuse_total":25,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"20729832","pmcid":"PMC2952063","openalex_id":"https://openalex.org/W2085544302","authors":[],"funders":[{"funder_name":"NIGMS NIH HHS","grant_id":"GM 62653","title":null},{"funder_name":"NIGMS NIH HHS","grant_id":"R01 GM041347","title":null},{"funder_name":"NIGMS NIH HHS","grant_id":"R01 GM062653","title":null},{"funder_name":"NIGMS NIH HHS","grant_id":"R37 GM062653","title":null},{"funder_name":"National Institutes of Health","grant_id":"5R01GM041347-06","title":"BIOCHEMICAL MECHANISM AND FUNCTION OF DNA HELICASES"},{"funder_name":"National Institutes of Health","grant_id":"5R37GM062653-22","title":"MECHANISTIC STUDIES OF GENETIC RECOMBINATION"}],"total_grants":6,"fwci":18.6507,"citation_percentile":0.99613277,"influential_citations":51,"citation_trend":[{"year":2012,"count":34},{"year":2013,"count":43},{"year":2014,"count":39},{"year":2015,"count":38},{"year":2016,"count":53},{"year":2017,"count":48},{"year":2018,"count":38},{"year":2019,"count":40},{"year":2020,"count":57},{"year":2021,"count":60},{"year":2022,"count":45},{"year":2023,"count":42},{"year":2024,"count":55},{"year":2025,"count":36},{"year":2026,"count":15}],"oa_status":"closed","license":"Springer TDM","oa_locations":[{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952063","host_type":"GREEN"},{"url":"http://www.nature.com/articles/nature09399.pdf","host_type":"publisher"},{"url":"http://www.nature.com/articles/nature09399","host_type":"publisher"},{"url":"https://doi.org/10.1038/nature09399","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/20729832","host_type":"repository"},{"url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.796.5645","host_type":""},{"url":"https://www.nature.com/articles/nature09399","host_type":"repository"},{"url":"https://escholarship.org/uc/item/5vf54085","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2952063","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC2952063","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC2952063?pdf=render","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/pmc2952063?pdf=render","host_type":""},{"url":"http://dx.doi.org/10.1038/nature09399","host_type":""},{"url":"https://dx.doi.org/10.1038/nature09399","host_type":""},{"url":"https://escholarship.org/content/qt5vf54085/qt5vf54085.pdf","host_type":""},{"url":"https://doi.org/https://doi.org/10.1038/nature09399","host_type":""}],"fields_of_study":["DNA Repair Mechanisms","BRCA gene mutations in cancer","CRISPR and Genetic Engineering","Medicine","Biology","Amino Acid Motifs","Apoptosis Regulatory Proteins","BRCA2 Protein","Cell Cycle Proteins","Cell Line","Chromosomal Instability","DNA","DNA Repair","DNA, Single-Stranded","DNA-Binding Proteins","Humans","Mutation","Protein Binding","Rad51 Recombinase","Recombination, Genetic","Replication Protein A","Sequence Homology, Nucleic Acid","Substrate Specificity"],"mesh_terms":["Cell Line","DNA","DNA Repair","DNA-Binding Proteins","DNA, Single-Stranded","Humans","Mutation","Protein Binding","Recombination, Genetic","Sequence Homology, Nucleic Acid","Substrate Specificity","Cell Cycle Proteins","Amino Acid Motifs","BRCA2 Protein","Chromosomal Instability","Apoptosis Regulatory Proteins","Rad51 Recombinase","Replication Protein A"],"keywords":["RAD51","Homologous recombination","Replication protein A","BRCA2 Protein","DNA","DNA repair","Biology","Cell biology","DNA damage","Chemistry","Molecular biology","Mutation","Gene","Genetics","DNA-binding protein","Germline mutation","Transcription factor","BRCA2 Protein (mesh)","DNA-Binding Proteins (mesh)","Women's Health (rcdc)","General Science & Technology (science-metrix)","Amino Acid Motifs","Sequence Homology","Cell Cycle Proteins","3105 Genetics (for-2020)","Cell Cycle Proteins (mesh)","Substrate Specificity","Rad51 Recombinase (mesh)","Single-Stranded","Protein Binding (mesh)","2.1 Biological and endogenous factors","Apoptosis Regulatory Proteins (mesh)","Aetiology","32 Biomedical and Clinical Sciences (for-2020)","Cancer","Cancer (rcdc)","Recombination, Genetic","Humans (mesh)","Mutation (mesh)","Biological Sciences","Nucleic Acid (mesh)","DNA-Binding Proteins","Breast Cancer (rcdc)","Substrate Specificity (mesh)","Single-Stranded (mesh)","Amino Acid Motifs (mesh)","Protein Binding","General Science & Technology","1.1 Normal biological development and functioning","Oncology and Carcinogenesis","Replication Protein A (mesh)","DNA, Single-Stranded","Article","Cell Line","Rare Diseases (rcdc)","Ovarian Cancer (rcdc)","Genetic","Underpinning research","Chromosomal Instability","Sequence Homology, Nucleic Acid","Breast Cancer","Humans","DNA Repair (mesh)","31 Biological Sciences (for-2020)","Biomedical and Clinical Sciences","Nucleic Acid","Genetics (rcdc)","Chromosomal Instability (mesh)","2.1 Biological and endogenous factors (hrcs-rac)","Cancer (hrcs-hc)","Recombination","3101 Biochemistry and Cell Biology (for-2020)","3211 Oncology and Carcinogenesis (for-2020)","Cell Line (mesh)","Genetic (mesh)","Biochemistry and Cell Biology","DNA (mesh)","Rad51 Recombinase","Apoptosis Regulatory Proteins"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.20279396.v1","title":"Additional file 1 of Plasmodium berghei Brca2 is required for normal development and differentiation in mice and mosquitoes","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.20279396","title":"Additional file 1 of Plasmodium berghei Brca2 is required for normal development and differentiation in mice and mosquitoes","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.20279399.v1","title":"Additional file 2 of Plasmodium berghei Brca2 is required for normal development and differentiation in mice and mosquitoes","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.20279399","title":"Additional file 2 of Plasmodium berghei Brca2 is required for normal development and differentiation in mice and mosquitoes","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.20279402.v1","title":"Additional file 3 of Plasmodium berghei Brca2 is required for normal development and differentiation in mice and mosquitoes","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.20279402","title":"Additional file 3 of Plasmodium berghei Brca2 is required for normal development and differentiation in mice and mosquitoes","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.21009546.v1","title":"Additional file 1 of The histone modification reader ZCWPW1 promotes double-strand break repair by regulating cross-talk of histone modifications and chromatin accessibility at meiotic hotspots","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.21009546","title":"Additional file 1 of The histone modification reader ZCWPW1 promotes double-strand break repair by regulating cross-talk of histone modifications and chromatin accessibility at meiotic hotspots","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.21009555.v1","title":"Additional file 4 of The histone modification reader ZCWPW1 promotes double-strand break repair by regulating cross-talk of histone modifications and chromatin accessibility at meiotic hotspots","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.21009555","title":"Additional file 4 of The histone modification reader ZCWPW1 promotes double-strand break repair by regulating cross-talk of histone modifications and chromatin accessibility at meiotic hotspots","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26623189.v1","title":"Additional file 1 of RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26623189","title":"Additional file 1 of RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26629008.v1","title":"Additional file 1 of miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26629008","title":"Additional file 1 of miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26759639.v1","title":"Additional file 3 of miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26629965.v1","title":"Additional file 2 of miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26629965","title":"Additional file 2 of miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26759639","title":"Additional file 3 of miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26623192","title":"Additional file 2 of RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26623192.v1","title":"Additional file 2 of RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26623195","title":"Additional file 3 of RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26623201","title":"Additional file 5 of RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26623195.v1","title":"Additional file 3 of RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26623198","title":"Additional file 4 of RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma","publisher":"figshare","resource_type":"Image"},{"doi":"10.6084/m9.figshare.26623201.v1","title":"Additional file 5 of RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma","publisher":"figshare","resource_type":"Image"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-13T20:53:56.172489Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}